TWST Twist Bioscience Corporation Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
15:32
Oct 08
moodywriter13
Avoid TWST as bubble story
Calls $TWST a potential AI-biotech winner but says it is not an investment case; labels it a bubble contender and notes it led the 2021 biotech bubble and still loses money, so buyers get story not business.
TWST Twist Bioscience Corporation Avoid — —
18:44
Oct 06
Martin Shkreli
Short AI drug dev plays pre-IND
Short AI-hype drug developers like Twist Bioscience because they have not yet borne the cost and friction of actual IND-enabling toxicology work; the market is pricing easy science that becomes expensive and dilutive in the clinic.
TWST Twist Bioscience Corporation Short — —
18:07
Oct 05
Martin Shkreli
Short AI drug devs on tox costs
Short Twist Bioscience as one of the AI-hyped drug development plays; Shkreli argues costly IND-enabling tox and clinical execution, not AI narratives, will expose overvalued developers.
TWST Twist Bioscience Corporation Short 1ST — —
Log in to see ideas

About TWST Investor Commentary

Across the available history and selected sources, Buzzberg tracks TWST (Twist Bioscience Corporation) across 23 sources: 5 bullish vs 2 bearish calls from 23 authors. Historical directional balance: 8% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 38 total trade ideas tracked. Past 7 days, before deduplication: 3 other directions. Latest voices: moodywriter13, Martin Shkreli.